Product Description: CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction[1][2].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Xu Y, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014 Jun 12;123(24):3750-9. /[2]Li X, et al. CD19, from bench to bedside. Immunol Lett. 2017 Mar;183:86-95.
Molecular Weight: N/A
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: CD19;Liposome
English
Deutsch
